Su‐Wei Chang

1.2k total citations
34 papers, 694 citations indexed

About

Su‐Wei Chang is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Su‐Wei Chang has authored 34 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Su‐Wei Chang's work include Asthma and respiratory diseases (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Immune Cell Function and Interaction (5 papers). Su‐Wei Chang is often cited by papers focused on Asthma and respiratory diseases (7 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Immune Cell Function and Interaction (5 papers). Su‐Wei Chang collaborates with scholars based in Taiwan, United States and Canada. Su‐Wei Chang's co-authors include Evelyn J. Bromet, Camilo J. Ruggero, Gabrielle A. Carlson, Marsha Tanenberg‐Karant, Roman Kotov, Laura J. Fochtmann, Hui‐Ju Tsai, Jing‐Long Huang, Tsung‐Chieh Yao and Man‐Chin Hua and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Su‐Wei Chang

32 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su‐Wei Chang Taiwan 12 182 177 93 92 92 34 694
Atsushi Kamijo Japan 17 114 0.6× 83 0.5× 58 0.6× 47 0.5× 140 1.5× 52 645
Rebecca L. Ross United Kingdom 16 128 0.7× 57 0.3× 82 0.9× 350 3.8× 69 0.8× 42 850
Eslie Dennis United States 10 51 0.3× 162 0.9× 112 1.2× 99 1.1× 57 0.6× 18 1000
Isabelle A. Vallerand Canada 15 185 1.0× 33 0.2× 35 0.4× 115 1.3× 138 1.5× 29 959
Tessel E. Galesloot Netherlands 16 73 0.4× 62 0.4× 38 0.4× 142 1.5× 88 1.0× 30 962
Valeria Nucera Italy 12 117 0.6× 57 0.3× 54 0.6× 65 0.7× 36 0.4× 19 477
Jan Eldh Sweden 12 50 0.3× 246 1.4× 36 0.4× 205 2.2× 191 2.1× 18 1.1k
Linda Charles United States 15 95 0.5× 84 0.5× 353 3.8× 114 1.2× 37 0.4× 19 755
Changjing Wu China 13 110 0.6× 37 0.2× 61 0.7× 83 0.9× 87 0.9× 25 390
Edward J. Pisko United States 14 96 0.5× 60 0.3× 38 0.4× 54 0.6× 44 0.5× 34 700

Countries citing papers authored by Su‐Wei Chang

Since Specialization
Citations

This map shows the geographic impact of Su‐Wei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Wei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Wei Chang more than expected).

Fields of papers citing papers by Su‐Wei Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Wei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Wei Chang. The network helps show where Su‐Wei Chang may publish in the future.

Co-authorship network of co-authors of Su‐Wei Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Wei Chang. A scholar is included among the top collaborators of Su‐Wei Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Wei Chang. Su‐Wei Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Ding‐Ping, Su‐Wei Chang, Ying-Hao Wen, & Wei‐Ting Wang. (2022). Association between diminished miRNA expression and the disease status of AML patients: Comparing to healthy control. Biomedical Journal. 46(2). 100518–100518. 4 indexed citations
3.
Chen, Ting‐Huei, Chien-Ching Chang, Pei‐Lung Chen, et al.. (2022). Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes. Communications Biology. 5(1). 1175–1175. 15 indexed citations
4.
5.
Chang, Ming‐Ling, Su‐Wei Chang, Rong‐Nan Chien, et al.. (2021). Genetic Association of Hepatitis C-Related Mixed Cryoglobulinemia: A 10-Year Prospective Study of Asians Treated with Antivirals. Viruses. 13(3). 464–464. 7 indexed citations
6.
Chen, Ding‐Ping, et al.. (2021). Single nucleotide polymorphisms within HLA region are associated with the outcomes of unrelated cord blood transplantation. Scientific Reports. 11(1). 21925–21925. 3 indexed citations
7.
Chang, Su‐Wei, Shih-Chieh Lee, Wai‐Jane Ho, et al.. (2020). Hypoglycemic Effect of Electroacupuncture Combined with Antrodia cinnamomea in Dexamethasone-Induced Insulin-Resistant Rats. Medical Acupuncture. 33(1). 58–64. 5 indexed citations
8.
Chen, Ding‐Ping, et al.. (2019). Association between single nucleotide polymorphisms within HLA region and disease relapse for patients with hematopoietic stem cell transplantation. Scientific Reports. 9(1). 13731–13731. 8 indexed citations
9.
Chang, Su‐Wei, Mei‐Ling Cheng, Ming‐Shi Shiao, et al.. (2018). Recovery of lipid metabolic alterations in hepatitis C patients after viral clearance: Incomplete restoration with accelerated ω-oxidation. Journal of clinical lipidology. 12(3). 756–766. 11 indexed citations
10.
Chang, Ying‐Hsu, Su‐Wei Chang, Po‐Hung Lin, et al.. (2018). Demographic characteristics and complications of open and minimal invasive surgeries for renal cell carcinoma: a population-based case–control study in Taiwan. Therapeutics and Clinical Risk Management. Volume 14. 1235–1241. 5 indexed citations
11.
Tsai, Hui‐Ju, et al.. (2017). Exposure to Tobacco Smoke and Childhood Rhinitis: A Population-Based Study. Journal of Allergy and Clinical Immunology. 139(2). AB24–AB24. 1 indexed citations
12.
Yao, Tsung‐Chieh, Hui‐Ju Tsai, Su‐Wei Chang, et al.. (2017). Obesity disproportionately impacts lung volumes, airflow and exhaled nitric oxide in children. PLoS ONE. 12(4). e0174691–e0174691. 38 indexed citations
13.
Chang, Ming‐Ling, Mei‐Ling Cheng, Su‐Wei Chang, et al.. (2016). Recovery of pan-genotypic and genotype-specific amino acid alterations in chronic hepatitis C after viral clearance: transition at the crossroad of metabolism and immunity. Amino Acids. 49(2). 291–302. 9 indexed citations
14.
Chang, Chih‐Jung, et al.. (2015). Impact on Time Gap Between Approval and Reimbursement of Target Therapy to Advanced Colorectal Cancer. Value in Health. 18(7). A486–A487. 1 indexed citations
15.
Yao, Tsung‐Chieh, Yu‐Ling Tu, Su‐Wei Chang, et al.. (2014). Serum 25-Hydroxyvitamin D Levels in Relation to Lung Function and Exhaled Nitric Oxide in Children. The Journal of Pediatrics. 165(6). 1098–1103.e1. 32 indexed citations
16.
Hsieh, Ai‐Ru, Su‐Wei Chang, Pei‐Lung Chen, et al.. (2014). Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese population. BMC Genomics. 15(1). 81–81. 10 indexed citations
17.
Yao, Tsung‐Chieh, Yu‐Ling Tu, Su‐Wei Chang, et al.. (2014). Suboptimal Vitamin D Status in a Population-Based Study of Asian Children: Prevalence and Relation to Allergic Diseases and Atopy. PLoS ONE. 9(6). e99105–e99105. 51 indexed citations
18.
Carlson, Gabrielle A., Roman Kotov, Su‐Wei Chang, Camilo J. Ruggero, & Evelyn J. Bromet. (2012). Early determinants of four‐year clinical outcomes in bipolar disorder with psychosis. Bipolar Disorders. 14(1). 19–30. 39 indexed citations
19.
Huang, Chengrui, Ke Li, Su‐Wei Chang, et al.. (2009). Family-based analysis of a myocardial infarction endophenotype: comparison of sampling designs. BMC Proceedings. 3(S7). S120–S120. 1 indexed citations
20.
Chang, Su‐Wei, Seung Hoan Choi, Ke Li, et al.. (2009). Growth mixture modeling as an exploratory analysis tool in longitudinal quantitative trait loci analysis. BMC Proceedings. 3(S7). S112–S112. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsushi Kamijo Breakdown of academic impact, for papers by Rebecca L. Ross Breakdown of academic impact, for papers by Eslie Dennis Breakdown of academic impact, for papers by Isabelle A. Vallerand Breakdown of academic impact, for papers by Tessel E. Galesloot Breakdown of academic impact, for papers by Valeria Nucera Breakdown of academic impact, for papers by Jan Eldh Breakdown of academic impact, for papers by Linda Charles Breakdown of academic impact, for papers by Changjing Wu Breakdown of academic impact, for papers by Edward J. Pisko
Rankless by CCL
2026